Nicotinamide riboside ameliorates survival time and motor dysfunction in an MPTP-Induced Parkinson's disease zebrafish model through effects on glucose metabolism and endoplasmic reticulum stress

被引:0
|
作者
Luo, Qing [1 ]
Yang, Yanmei [2 ]
Xian, Chunyan [1 ]
Zhou, Pan [1 ]
Zhang, Hui [1 ]
Lv, Zhiyu [2 ]
Liu, Jinbo [1 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Sichuan Prov Engn Technol Res Ctr Mol Diag Clin Di, Mol Diag Clin Dis Key Lab Luzhou,Dept Lab Med, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Neurol, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
关键词
Nicotinamide riboside; Parkinson's disease; Zebrafish; Endoplasmic reticulum stress; NEURODEGENERATION; TOXICITY;
D O I
10.1016/j.cbi.2024.111118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nicotinamide riboside (NR) is a precursor and exogenous supplement of nicotinamide adenine dinucleotide (NAD + ). NR has been shown to play a beneficial role in a variety of neurodegenerative diseases. A phase 1 clinical trial identified NR as a potential neuroprotective therapy for Parkinson ' s disease (PD). However, the mechanism of action of NR in PD has not been fully elucidated. Therefore, the present study aimed to investigate the potential effects of NR on a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model in zebrafish and its underlying mechanisms. The results showed that NR improved motor dysfunction, survival time, dopamine neurons, and peripheral neurons, as well as the NAD + levels in the MPTP-affected PD zebrafish model. In addition, transcriptome sequencing analysis revealed that, after NR treatment, differentially expressed genes were significantly enriched in the glucose metabolism and protein processing pathways in the endoplasmic reticulum (ER). Quantitative PCR (qPCR) revealed that the mRNA levels of the glycoheterotrophic enzyme (involved in glucose metabolism) were significantly decreased, and the glycolytic enzyme mRNA expression levels were significantly increased. The results of the non-targeted metabolomic analysis showed that NR treatment significantly increased the levels of metabolites such as nicotinic acid ,nicotinamide, D-glucose (from the gluconeogenesis and glycolysis metabolism pathways) and some glucogenic amino acids, such as glutamine. Importantly, NR ameliorated MPTP-induced endoplasmic reticulum stress (ERS) in the PD zebrafish model through the Perk-Eif2 alpha-Atf4-Chop pathway. These results highlight the neuroprotective effect of NR in the present PD zebrafish model through modulation of glucose metabolism and ERS via the Perk-Eif2 alpha-Atf4-Chop pathway and provide valuable mechanistic insights into the treatment of PD.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson's disease
    Song, Jiangbo
    Liu, Lian
    Li, Zhiquan
    Mao, Ting
    Zhang, Jianfei
    Zhou, Lei
    Chen, Xin
    Shang, Yunzhu
    Sun, Tao
    Luo, Yuxin
    Jiang, Yu
    Tan, Duan
    Tong, Xiaoling
    Dai, Fangyin
    BMC MEDICINE, 2022, 20 (01)
  • [22] Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson’s disease
    Jiangbo Song
    Lian Liu
    Zhiquan Li
    Ting Mao
    Jianfei Zhang
    Lei Zhou
    Xin Chen
    Yunzhu Shang
    Tao Sun
    Yuxin Luo
    Yu Jiang
    Duan Tan
    Xiaoling Tong
    Fangyin Dai
    BMC Medicine, 20
  • [23] Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson's disease
    Qian, Y.
    Yang, X.
    Xu, S.
    Xiao, Q.
    MOVEMENT DISORDERS, 2018, 33 : S800 - S800
  • [24] Effects of eugenol on the behavioral and pathological progression in the MPTP-induced Parkinson's disease mouse model
    Vora, Urmi
    Vyas, Vivek Kumar
    Wal, Pranay
    Saxena, Bhagawati
    DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (04): : 154 - 163
  • [25] Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway
    Shi, Liangqin
    Huang, Chao
    Luo, Qihui
    Xia, Yu
    Liu, Wentao
    Zeng, Wen
    Cheng, Anchun
    Shi, Riyi
    Chen Zhengli
    AGING-US, 2020, 12 (10): : 9515 - 9533
  • [26] Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson's Disease Model
    Hong, Dong Geun
    Lee, Seulah
    Kim, Jaehoon
    Yang, Seonguk
    Lee, Myunggyo
    Ahn, Jinsook
    Lee, Haeseung
    Chang, Seung-Cheol
    Ha, Nam-Chul
    Lee, Jaewon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [27] Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease
    Wang, Yaozhen
    Yu, Xiaofeng
    Zhang, Ping
    Ma, Yinglin
    Wang, Lei
    Xu, Huali
    Sui, Dayun
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 138 (01) : 31 - 37
  • [28] Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model
    Ho, Shih-Chun
    Hsu, Chih-Chuan
    Pawlak, Cornelius Rainer
    Tikhonova, Maria A.
    Lai, Te-Jen
    Amstislavskaya, Tamara G.
    Ho, Ying-Jui
    BEHAVIOURAL BRAIN RESEARCH, 2014, 268 : 177 - 184
  • [29] Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: A microarray study
    Gao, Li
    Li, Chao
    Yang, Ran-Yao
    Lian, Wen-Wen
    Fang, Jian-Song
    Pang, Xiao-Cong
    Qin, Xue-Mei
    Liu, Ai-Lin
    Du, Guan-Hua
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2015, 133 : 155 - 163
  • [30] Protective effects of prucalopride in MPTP-induced Parkinson's disease mice: Neurochemistry, motor function and gut barrier
    Shi, Yun
    Qiao, Chen-Meng
    Zhou, Yu
    Wu, Ji
    Cui, Chun
    Hong, Hui
    Jia, Xue-Bing
    Huang, Shu-Bing
    Yao, Li
    Zhao, Wei-Jiang
    Shen, Yan-Qin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 556 : 16 - 22